What Does BIND Stand For?
BIND stands for Biological Investigational New Drug
BIND, or Biological Investigational New Drug, refers to a category of therapeutic agents that are in the investigational phase of development and are derived from biological sources. These drugs are subject to rigorous preclinical and clinical testing to evaluate their safety, efficacy, and potential for regulatory approval. BINDs play a crucial role in advancing treatment options for various diseases and conditions by leveraging biological processes and molecules in their design and function.
Added on 27th September 2008 | Last edited on 16th June 2025 | Edit Acronym